STOCK TITAN

WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

WuXi AppTec (OTC:WUXAY), a global pharmaceutical and life sciences R&D and manufacturing services provider, has earned the EcoVadis Gold Medal for sustainability for the second consecutive year. The rating evaluates companies across environment, labor & human rights, ethics, and sustainable procurement criteria.

The company has received multiple sustainability recognitions, including five consecutive years of MSCI ESG Leadership Rating, four consecutive years in the Dow Jones Sustainability Index, and its first MSCI ESG AAA rating. WuXi AppTec has also obtained validation from the Science Based Targets initiative (SBTi) for its emissions reduction targets and participates in the UN Global Compact.

Loading...
Loading translation...

Positive

  • Received EcoVadis Gold Medal for second consecutive year
  • Achieved multiple prestigious sustainability recognitions including MSCI ESG AAA rating
  • Obtained SBTi validation for emissions reduction targets
  • Demonstrates strong commitment to ESG practices across global operations

Negative

  • None.

News Market Reaction 1 Alert

+2.90% News Effect

On the day this news was published, WUXAY gained 2.90%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SHANGHAI, Sept. 8, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced it has received the Gold Medal by EcoVadis sustainability rating for the second consecutive year. This achievement reflects WuXi AppTec's commitment to sustainability and its ongoing efforts to integrate environmental and social responsibilities into the Company's business strategies and operations.

EcoVadis is a leading sustainability rating agency for global supply chains. Its ratings assess companies based on 21 sustainability criteria across four main themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.

"We are honored to once again receive the EcoVadis Gold Medal. This recognition reflects the significant progress we have made in implementing sustainable development and robust practices throughout our entire value chain," said Dr. Steve Yang, Co-CEO of WuXi AppTec and Chairman of WuXi AppTec's Sustainability Committee. "We remain committed to advancing our sustainability initiatives while supporting our customers in bringing innovative therapies to patients worldwide."

As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec strategically integrates sustainability like most of the customers into its global operations. The Company's leadership in sustainability has been recognized by several prestigious organizations: WuXi AppTec has received the MSCI ESG Leadership Rating for five consecutive years, has been included in the Dow Jones Sustainability Index (DJSI) for four consecutive years. The Company has also earned an A- Leadership rating in the CDP Climate Change assessment, and has been recognized as an Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics, as well as included in the FTSE4Good Index Series for three consecutive years. Additionally, the Company has received its first MSCI ESG AAA rating, and achieved an A Leadership rating in the CDP Water Security assessment.

Furthering its sustainability commitments, WuXi AppTec has received validation from the Science Based Targets initiative (SBTi) for its near-term emissions reduction targets. The Company is also a participant in the United Nations Global Compact (UNGC), supporting its ten principles, and serves as a supplier partner to the Pharmaceutical Supply Chain Initiative (PSCI).

About WuXi AppTec

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com.

Cision View original content:https://www.prnewswire.com/news-releases/wuxi-apptec-awarded-gold-medal-by-ecovadis-sustainability-rating-for-second-consecutive-year-302547481.html

SOURCE WuXi AppTec

FAQ

What sustainability rating did WuXi AppTec (WUXAY) receive from EcoVadis in 2025?

WuXi AppTec received the Gold Medal from EcoVadis for the second consecutive year, reflecting their commitment to sustainability across environment, labor & human rights, ethics, and sustainable procurement.

What major ESG achievements has WuXi AppTec (WUXAY) received in recent years?

WuXi AppTec has received MSCI ESG Leadership Rating for 5 years, inclusion in DJSI for 4 years, an A- Leadership rating in CDP Climate Change assessment, and its first MSCI ESG AAA rating.

How is WuXi AppTec (WUXAY) addressing climate change commitments?

WuXi AppTec has received SBTi validation for its near-term emissions reduction targets and achieved an A Leadership rating in CDP Water Security assessment. The company also participates in the UN Global Compact.

What sustainability initiatives is WuXi AppTec (WUXAY) participating in?

WuXi AppTec participates in the United Nations Global Compact (UNGC), serves as a supplier partner to the Pharmaceutical Supply Chain Initiative (PSCI), and has validated targets with the Science Based Targets initiative.
Wuxi Apptec

OTC:WUXAY

WUXAY Rankings

WUXAY Latest News

WUXAY Stock Data

43.01B
2.50B
Diagnostics & Research
Healthcare
Link
China
Shanghai